e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Biomarkers and other new methods for lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Detection of patients with lung cancer out of a risk group by breath sample presentation to sniffer dogs
R. Ehmann, E. Boedeker, U. Friedrich, J. Sagert, T. Walles, G. Friedel (Stuttgart, Gerlingen, Löffingen, Germany)
Source:
Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Session:
Biomarkers and other new methods for lung cancer
Session type:
Thematic Poster Session
Number:
2787
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Ehmann, E. Boedeker, U. Friedrich, J. Sagert, T. Walles, G. Friedel (Stuttgart, Gerlingen, Löffingen, Germany). Detection of patients with lung cancer out of a risk group by breath sample presentation to sniffer dogs. Eur Respir J 2011; 38: Suppl. 55, 2787
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Evaluation of breath sampling procedures in lung cancer patients
Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology
Year: 2008
What is real prevalence of COPD in patients with lung cancer?
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008
Incidence of lung cancer among COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 494s
Year: 2005
Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon
Source: Eur Respir J 2012; 39: 669-676
Year: 2012
Role of progestrin releasing peptide (ProGRP), a serum based biomarker in early diagnosis of SCLC in cohort of high-risk patient presenting with symptoms related to lung cancer
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005
Stage I lung cancer patients with or without symptoms – are the patients any different?
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020
Symptomatic pattern, alarm symptoms and diagnostic delay in a cohort of 1277 lung cancer patients
Source: Eur Respir J 2003; 22: Suppl. 45, 360s
Year: 2003
Characteristics of nonsmoker lung cancer patients
Source: Eur Respir J 2006; 28: Suppl. 50, 781s
Year: 2006
Prevalence of and risk factors for pulmonary complications after lung cancer surgery in elderly patients with preserved lung function
Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Year: 2018
Influence of the lung resection to sleep disorders in patients with lung cancer – pilot study on 10 patients
Source: Annual Congress 2008 - Risk assessment and treatment of complications in thoracic surgery patients
Year: 2008
An electronic nose in the discrimination of patients with lung cancer and controls
Source: Annual Congress 2012 - Early detection of lung cancer
Year: 2012
Significance of febrile episode in patients with lung cancer during therapy - comparison of NSCLC and SCLC patients
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002
Analysis of the clinical feature of 383 patients with lung cancer
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
Prior lung disease and risk of lung cancer in women
Source: Eur Respir J 2005; 26: Suppl. 49, 598s
Year: 2005
Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009
Early detection of lung cancer in patients with COPD by eNose technology
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018
Features of an estimation of the functional condition of patients with complicated lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 11s
Year: 2004
Pulmonary function testing in patients with lung cancer
Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology
Year: 2012
Evaluation of cancer-associated thrombosis risk in patients with lung adenocarcinoma using the COMPASS-CAT risk assessment model
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept